Applied UV, Inc. (NASDAQ:AUVI) Analysts Are Pretty Bullish On The Stock After Recent Results

Shareholders might have noticed that Applied UV, Inc. (NASDAQ:AUVI) filed its second-quarter result this time last week. The early response was not positive, with shares down 5.5% to US$1.73 in the past week. Revenues came in 61% better than analyst models expected, at US$5.9m, although statutory losses ballooned 66% to US$0.26, which is much worse than what was forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Applied UV after the latest results.

See our latest analysis for Applied UV

earnings-and-revenue-growth
earnings-and-revenue-growth

After the latest results, the three analysts covering Applied UV are now predicting revenues of US$19.0m in 2022. If met, this would reflect a meaningful 13% improvement in sales compared to the last 12 months. The loss per share is expected to ameliorate slightly, reducing to US$0.73. Before this latest report, the consensus had been expecting revenues of US$16.4m and US$0.65 per share in losses. So there's been quite a change-up of views after the recent consensus updates, with the analysts significantly increasing their revenue forecasts while also expecting losses per share to increase. It looks like the revenue growth will not be achieved without incremental costs.

The average price target rose 16% to US$9.20, even thoughthe analysts have been updating their forecasts to show higher revenues and higher forecast losses. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Applied UV at US$10.40 per share, while the most bearish prices it at US$8.00. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's pretty clear that there is an expectation that Applied UV's revenue growth will slow down substantially, with revenues to the end of 2022 expected to display 28% growth on an annualised basis. This is compared to a historical growth rate of 147% over the past year. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 4.4% per year. Even after the forecast slowdown in growth, it seems obvious that Applied UV is also expected to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts increased their loss per share estimates for next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Applied UV going out to 2024, and you can see them free on our platform here..

However, before you get too enthused, we've discovered 5 warning signs for Applied UV (2 are concerning!) that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here